This work builds on our recent studies, from defining senescent hepatocytes & senotherapies in MASLD to conceptual frameworks on dynamic senescence in liver disease.
https://t.co/71Hax9Qn0z
https://t.co/5p9kNVThAH
https://t.co/UEeLvMTHkp
Thrilled to share our latest @gut_bmj work on alcohol-associated liver disease (ALD), uncovering how a RBP regulates hepatocyte senescence & disease progression: https://t.co/oFsb59OA7V
This extends our program from MASLD to ALD and broader chronic liver disease! 🙌
Feeling truly grateful to @AASLDtweets
for the Travel Award and the opportunity to present a Basic Science Plenary talk! 🙏 Thanks to Dr. Anna Mae Diehl and @Duke_GI for their incredible support. Excited to keep exploring how aging and cellular senescence drive liver disease!
Aging exacerbates MASLD by inducing ferroptotic stress. By reducing this stress, we can reverse the disease. These findings hold promise for millions with MASLD!
Online now! A new study by @kuo_du et al. shows that aging promotes metabolic dysfunction-associated steatotic liver disease by inducing ferroptotic stress in mice.
(https://t.co/sCOiQsmEXn)
https://t.co/foD6aat3ll
Online now! A new study by @kuo_du et al. shows that aging promotes metabolic dysfunction-associated steatotic liver disease by inducing ferroptotic stress in mice.
(https://t.co/sCOiQsmEXn)
https://t.co/foD6aat3ll